Root (ROOT)
(Delayed Data from NSDQ)
$66.81 USD
+2.41 (3.74%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $67.03 +0.22 (0.33%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.81 USD
+2.41 (3.74%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $67.03 +0.22 (0.33%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth F Momentum C VGM
Zacks News
Arch Capital (ACGL) Up 35% in a Year: More Room for Upside?
by Zacks Equity Research
New business opportunities, rate increases, growth in existing accounts and a solid capital position continue to drive Arch Capital (ACGL).
Should You Retain Travelers (TRV) Stock in Your Portfolio?
by Zacks Equity Research
Travelers (TRV) stands to benefit from strong net earned premiums, high levels of retention, improved pricing and sufficient liquidity.
Reasons Why Kinsale Capital (KNSL) Stock is a Solid Pick Now
by Zacks Equity Research
Kinsale Capital (KNSL) is poised to grow on solid E&S market, strong premium growth, low expense ratio, higher margins and prudent capital deployment.
Is It Time to Add Horace Mann (HMN) Stock to Your Kitty Now?
by Zacks Equity Research
A focus on improving product offerings, strengthening distribution and modernizing infrastructure bodes well for Horace Mann (HMN).
Here's Why You Should Hold on to CNA Financial (CNA) Stock
by Zacks Equity Research
CNA Financial (CNA) is poised to grow on improved current accident year underwriting results and growth in invested asset base and sufficient liquidity.
Palomar (PMR) Debuts in Crop Insurance With Advanced AgProtection
by Zacks Equity Research
Palomar's (PLMR) long-term fronting arrangement with Advanced AgProtection makes it the 14th approved insurance provider in the United States by the Federal Crop Insurance Corporation as well as entry into the crop insurance sector.
Here's Why You Should Add Trupanion (TRUP) to Your Portfolio
by Zacks Equity Research
Trupanion (TRUP) is poised for growth in a total addressable market of $34.1 billion, given the change in the attitude of pet owners who are increasingly focusing on pets' health and well-being.
Employers Holdings (EIG) Up 23% in 3 Months: More Room for Rally?
by Zacks Equity Research
Niche focus on low-to-medium hazard risk small businesses, better pricing, investment in technology, solid capital position and effective capital deployment continue to drive Employers Holdings (EIG).
Reasons Why Investors Should Retain Chubb Limited (CB) Stock
by Zacks Equity Research
Chubb Limited (CB) stands to gain from improving rate environment, expanding underwriting margins, strategic acquisitions and effective capital deployment.
Here's Why Should You Hold Primerica (PRI) Stock in Portfolio
by Zacks Equity Research
Compelling portfolio, strong market presence and solid capital position poise Primerica (PRI) well for growth.
Reasons Why You Should Retain Selective Insurance (SIGI) Stock
by Zacks Equity Research
Selective Insurance (SIGI) is well-poised to gain from renewal pure price increases, higher direct new business, higher returns on alternative investments and solid capital position.
Rising P/E: An Overlooked Way to Pick 5 Winning Stocks
by Sanghamitra Saha
Want to try a different approach? Tap five stocks with increasing P/E ratios. These include CuriosityStream (CURI), Root (ROOT), LendingClub (LC), Manitex International (MNTX) and Zynerba Pharmaceuticals (ZYNE).
American Equity (AEL) Up 14% in a Year: More Room for Upside?
by Zacks Equity Research
The increasing popularity of index products in the market, focus on expansion into new verticals, solid balance sheet and effective capital continue to drive American Equity (AEL).
Reinsurance Group (RGA) Gains 29% in a Year: Will the Rally Last?
by Zacks Equity Research
Improved pricing, business expansion in the pension risk transfer market, solid in-force business ensuring predictable long-term earnings and effective capital deployment continue to drive Reinsurance Group (RGA).
Should You Retain Willis Towers (WTW) in Your Portfolio?
by Zacks Equity Research
Willis Towers (WTW) is poised to benefit from growth across global lines of business, strategic inorganic expansion, contributions from M&A solutions and effective capital deployment.
Reasons Why First American (FAF) Stock is a Solid Pick Now
by Zacks Equity Research
Increased domestic residential purchase and commercial transactions, strategic buyouts and higher average invested balances continue to drive First American (FAF).
Why You Should Hold on to American Financial (AFG) Stock
by Zacks Equity Research
American Financial (AFG) is well-poised for growth on business opportunities, acquisitions, favorable estimates and improved guidance.
Here's Why Hold is an Apt Strategy for NMI Holdings (NMIH) Now
by Zacks Equity Research
NMI Holdings (NMIH) is well-poised for growth owing to the increasing size of the U.S. mortgage insurance market, expansion of customer franchise and a well-performing reinsurance market.
Arthur J. Gallagher (AJG) Acquires ROC Group, Boosts Portfolio
by Zacks Equity Research
Arthur J. Gallagher's (AJG) acquisition of ROC Group is likely to strengthen existing benefits and HR offerings.
Should You Retain Markel (MKL) Stock in Your Portfolio?
by Zacks Equity Research
Markel (MKL) is well poised to gain from favorable rates, growth across all its product lines, higher earned premiums and prudent capital deployment.
Reasons Why Investors Should Retain Sun Life (SLF) Stock Now
by Zacks Equity Research
Sun Life Financial (SLF) is well-poised to gain from strategic buyouts, higher large-case group benefits sales, business growth, prudent capital deployment and sufficient liquidity.
Everest Re (RE) Rallies 22% YTD: Can It Retain the Momentum?
by Zacks Equity Research
New business growth, strong renewal retention, continued favorable rate increases and a solid capital position continue to drive Everest Re (RE).
Is it Time to Add Argo Group (ARGO) Stock to Your Portfolio?
by Zacks Equity Research
Highly profitable business, growth efforts, expense initiative program, investment in technology and a solid capital position poise Argo Group (ARGO) for growth.
Zacks.com featured highlights include Clovis Oncology, NiSource, DocuSign, Root and Endava
by Zacks Equity Research
Clovis Oncology, NiSource, DocuSign, Root and Endava are part of the Zacks Screen of the Week article.
Should You Hold Manulife Financial (MFC) in Your Portfolio?
by Zacks Equity Research
Manulife Financial (MFC) stands to gain from in-force business growth in Canada and Asia, strategic buyouts, robust capital position and effective capital deployment.